Import, Export Restrictions Imposed on Stimulant

The Drug Enforcement Administration has issued an interim final rule placing centanafadine, including its salts, isomers (whether optical, positional, or geometric), and salts of such isomers, in schedule III of the CSA. Comments are due no later than Nov. 30.

This substance is a stimulant recently approved by the Food and Drug Administration for the treatment of attention deficit/hyperactivity disorder.

This rule imposes schedule III regulatory controls and administrative, civil, and criminal sanctions applicable to the manufacture, distributing, dispensing, importing, exporting, research, and conduct of instructional activities of this substance.